"Adrenal Gland Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the ADRENAL GLANDS.
Descriptor ID |
D000310
|
MeSH Number(s) |
C04.588.322.078 C19.053.347 C19.344.078
|
Concept/Terms |
Adrenal Gland Neoplasms- Adrenal Gland Neoplasms
- Adrenal Gland Neoplasm
- Neoplasm, Adrenal Gland
- Adrenal Neoplasm
- Adrenal Neoplasms
- Neoplasm, Adrenal
- Neoplasms, Adrenal
- Neoplasms, Adrenal Gland
Adrenal Cancer- Adrenal Cancer
- Adrenal Cancers
- Cancer, Adrenal
- Cancers, Adrenal
- Cancer of the Adrenal Gland
- Adrenal Gland Cancer
- Adrenal Gland Cancers
- Cancer, Adrenal Gland
- Cancers, Adrenal Gland
|
Below are MeSH descriptors whose meaning is more general than "Adrenal Gland Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Adrenal Gland Neoplasms".
This graph shows the total number of publications written about "Adrenal Gland Neoplasms" by people in this website by year, and whether "Adrenal Gland Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 4 | 1 | 5 |
1995 | 4 | 1 | 5 |
1996 | 2 | 1 | 3 |
1997 | 2 | 1 | 3 |
1998 | 1 | 2 | 3 |
1999 | 2 | 1 | 3 |
2000 | 3 | 1 | 4 |
2001 | 2 | 0 | 2 |
2002 | 3 | 1 | 4 |
2003 | 4 | 1 | 5 |
2004 | 4 | 2 | 6 |
2005 | 7 | 0 | 7 |
2006 | 5 | 0 | 5 |
2007 | 8 | 0 | 8 |
2008 | 9 | 0 | 9 |
2009 | 8 | 0 | 8 |
2010 | 8 | 3 | 11 |
2011 | 5 | 1 | 6 |
2012 | 8 | 1 | 9 |
2013 | 10 | 1 | 11 |
2014 | 5 | 0 | 5 |
2015 | 7 | 1 | 8 |
2016 | 5 | 1 | 6 |
2017 | 10 | 0 | 10 |
2018 | 12 | 3 | 15 |
2019 | 6 | 0 | 6 |
2020 | 15 | 0 | 15 |
2021 | 9 | 0 | 9 |
2022 | 12 | 0 | 12 |
2023 | 10 | 0 | 10 |
2024 | 9 | 0 | 9 |
To return to the timeline,
click here.
Below are the most recent publications written about "Adrenal Gland Neoplasms" by people in Profiles.
-
SDHB-Associated Pheochromocytomas: What is Their Clinical Behavior? Ann Surg Oncol. 2024 Dec; 31(13):9007-9013.
-
Metastatic pheochromocytoma and paraganglioma: Integrating tumor biology in clinical practice. Mol Cell Endocrinol. 2024 Oct 01; 592:112344.
-
International consensus statement on the diagnosis and management of phaeochromocytoma and paraganglioma in children and adolescents. Nat Rev Endocrinol. 2024 Dec; 20(12):729-748.
-
Management of metastatic pheochromocytomas and paragangliomas: when and what. Curr Probl Cancer. 2024 Aug; 51:101116.
-
Adverse skeletal related events in patients with bone-metastatic pheochromocytoma/paraganglioma. Eur J Cancer. 2024 Sep; 208:114122.
-
Performance of CT With Adrenal-Washout Protocol in Heterogeneous Adrenal Nodules: A Multiinstitutional Study. AJR Am J Roentgenol. 2024 05; 222(5):e2330769.
-
High-Specific-Activity 131 I-MIBG for the Treatment of Advanced Pheochromocytoma and Paraganglioma. Clin Nucl Med. 2024 Jul 01; 49(7):610-620.
-
Cabozantinib in patients with unresectable and progressive metastatic phaeochromocytoma or paraganglioma (the Natalie Trial): a single-arm, phase 2 trial. Lancet Oncol. 2024 May; 25(5):658-667.
-
Beyond the three P's: adrenal involvement in MEN1. Endocr Relat Cancer. 2024 Feb 01; 31(2).
-
Management of phaeochromocytoma and paraganglioma in patients with germline SDHB pathogenic variants: an international expert Consensus statement. Nat Rev Endocrinol. 2024 Mar; 20(3):168-184.